Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 11, 2021

Primary Completion Date

January 16, 2026

Study Completion Date

January 16, 2026

Conditions

Alzheimer DiseaseAnxietyAgitation,PsychomotorMild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Interventions

DRUG

high CBD/low THC sublingual solution

Hemp derived solution to be administered sublingually twice daily.

Trial Locations (1)

RECRUITING

McLean Hospital, Belmont

All Listed Sponsors

collaborator

Spier Family Foundation

UNKNOWN

lead

Mclean Hospital

OTHER